Following extraordinary investment, expansion, and innovation in 2021, the life sciences industry is poised for further growth and consistent demand in the years ahead.
Going forward, capitalising on the latest trends in technology will be more critical than ever as these advancements are continuously reshaping the way we research, develop, test, go to market and analyse data in life sciences. Even though its trajectory is intact, the sector is not immune, however, to overarching economic factors like inflation, higher interest rates and tightening capital markets, which are impacting investors and life sciences companies looking to occupy space within a tight budget.
Life Sciences Market Summaries
Select each market on the map below to view an in-depth life sciences market summary for that city.
INTERESTED IN MORE?
Read the full report and explore the market-by-market analysis.
Real Estate Fundamentals Remain Strong
The life sciences sector has experienced outsized growth in the last seven years.
UK life sciences rents have grown 63% since 2017, on par with U.S. markets. Growth has slowed in some markets but remains above 2019 pre-pandemic levels.
U.S. asking rents are 67% higher, on average, than in 2015, and inventory has grown in tandem by 29% across the markets tracked by Cushman & Wakefield Research.
Flow of Funding
The global life sciences venture capital funding market experienced a slowdown in the first half of 2022 relative to the same period in 2021.
Future Demand
The flow of venture capital into the life sciences sector has accelerated the growth of new companies with seed and early-stage companies still experiencing significant momentum.
For the markets tracked by Cushman & Wakefield, 55.20% of the VC deals into life science companies with a UK presence through to the end of August 2022, involved pre or early-stage VC deals, with an average deal size across all VC investments of £11.65 million.
WEBINAR REPLAY | LIFE SCIENCES UPDATE
This 2022 Life Sciences Update webinar breaks down the current trends in the life sciences industry by exploring:
Subscribe to Life Sciences Insights
Get the latest in Cushman & Wakefield's Life Sciences research and commentary.
Subscribe
Learn More
Contacts
Related insights
Article
Does your building qualify for a life sciences conversion?
Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require.
Eric Giles • 18/07/2023
Article
Challenges for Life Sciences Projects Means Early Engagement of Project Managers
Persistent challenges continue to impact costs, material lead times and project timelines across all life sciences projects.
Jason D'Orlando • 30/06/2023
Article
Life Science Update: Finding Talent and Fostering New Ideas
Encouraging collaboration to formulate new ideas and creating access to skilled talent remain priorities for life sciences companies. Among current life science industry trends, there are several hot locations for the life sciences, as well as a focus on amenities that spark ‘spontaneous interactions’.
Rachel Park • 19/10/2022